相关实验视频
Updated: Jul 10, 2025

04:08
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
Published on: June 27, 2025
51
胎盘增生或胎盘增生的临床危险因素:一个病例对照研究
Ingrid Noël1, Louise Ghesquiere2, Paul Guerby3
1Department of Obstetrics and Gynecology, Faculty of Medicine, Université Laval, QC; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ottawa, Ottawa, ON.
概括
以前的子宫手术和多次剖腹产显著增加了胎盘积分谱 (PAS) 障碍的风险. 吸烟和短的分娩间隔也会导致PAS的发展,需要在高风险怀孕中仔细考虑.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 手术结果研究研究.
背景情况:
- 从先前剖腹产产产生的子宫痕是已知的胎盘增生谱系 (PAS) 障碍的风险因素.
- 帕斯与显著的孕产妇发病率有关,包括需要切除子宫的必要性.
研究的目的:
- 在有剖腹产史的妇女中确定PAS的特定风险因素.
- 为临床实践和患者咨询提供有关PAS风险的信息.
主要方法:
- 进行了一项病例对照研究,比较了为PAS (病例) 切除子宫的妇女与以前分娩的剖腹产分娩的妇女 (对照).
- 使用单变量和多变量逻辑回归分析了母亲和之前的剖腹产特征.
主要成果:
- 以前的子宫手术史 (OR 27.4) 和之前的剖腹产数量 (OR 7.2-7.9) 与PAS有很强的关联.
- 在曾经经做过一次剖腹产的女性中,分娩间隔<18个月 (OR 6.3) 和吸烟 (OR 5.8) 是显著的危险因素.
- 在剖腹产前的妊娠年龄和宫扩张与PAS无关.
结论:
- 以前的子宫手术,多次剖腹产,吸烟和短的分娩间隔是PAS需要切除子宫的重要危险因素.
- 需要进一步的研究来评估前剖腹产期间子宫关闭技术对PAS风险的影响.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130
Relative Risk
185
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
185
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K

